ESC Premium Access

Vagal nerve stimulation ameliorates severe pulmonary arterial hypertension via anti-inflammatory effects in rats

Congress Presentation

About the speaker

Doctor Keimei Yoshida

Kyushu University, Fukuoka (Japan)
0 follower

9 more presentations in this session

Subcutaneous treprostinil for the treatment of non-operable chronic thromboembolic pulmonary hypertension: a randomized, controlled trial (CTREPH)

Speaker: Doctor R. Sadushi-Kolici (Vienna, AT)


A phase 3 study in an enriched population of pulmonary arterial hypertension patients with long term oxygen use demonstrating improved exercise tolerance with use of ambulatory inhaled nitric oxide

Speaker: Doctor H. Farber (Bollington, GB)


Comparative receptor pharmacology, pre-clinical efficacy and pharmacokinetics of a novel, next-generation prostacyclin receptor agonist, ralinepag (APD811), in humans and rats

Speaker: Doctor J. Adams (San Diego, US)


Cardiac magnetic resonance characterization of maladaptive right ventricular hypertrophy in chronic pulmonary hypertension.

Speaker: Doctor I. Garcia Lunar (Madrid, ES)


APD811 (ralinepag), a novel non-prostanoid IP receptor agonist, has potent antiproliferative and vasorelaxant properties in human pulmonary artery

Speaker: Doctor J. Patel (London, GB)


Access the full session

Progress in the management of pulmonary hypertension

Speakers: Doctor K. Yoshida, Doctor R. Sadushi-Kolici, Doctor H. Farber, Doctor J. Adams, Doctor I. Garcia Lunar...

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb